Copyright
©The Author(s) 2004.
World J Gastroenterol. Sep 15, 2004; 10(18): 2727-2730
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2727
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2727
Table 2 Subgroup analysis
| Characteristic | No. of trials | OR | 95%CI |
| IPT (without CH and IHCP) | 2 | 0.57 | (0.35-0.92) |
| IPT (only with CH) | 2 | 0.52 | (0.29-0.94) |
| IHCP | 7 | 0.48 | (0.35-0.67) |
| Follow-up time (mo) < 60 | 6 | 0.40 | (0.27-0.59) |
| Follow-up time (mo) ≥ 60 | 5 | 0.60 | (0.44-0.82) |
| Asia | 9 | 0.49 | (0.38-0.64) |
| Non-Asia (Austria) | 2 | 0.67 | (0.32-1.41) |
- Citation: Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004; 10(18): 2727-2730
- URL: https://www.wjgnet.com/1007-9327/full/v10/i18/2727.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i18.2727